scholarly article | Q13442814 |
P50 | author | Gayle Woloschak | Q37828777 |
Riad Salem | Q45736667 | ||
Reed A. Omary | Q86839285 | ||
P2093 | author name string | Laura M Kulik | |
Andrew C Larson | |||
Robert J Lewandowski | |||
Robert K Ryu | |||
Guang-Yu Yang | |||
Kent T Sato | |||
Mary F Mulcahy | |||
Sumeet Virmani | |||
Thomas K Rhee | |||
Barbara Szolc-Kowalska | |||
P2860 | cites work | A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation | Q24294741 |
Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway | Q24672316 | ||
Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases | Q28139317 | ||
The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages | Q28143066 | ||
Induction of HIF-1alpha in response to hypoxia is instantaneous | Q28188144 | ||
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 | ||
Hypoxia-induced angiogenesis in human hepatocellular carcinoma | Q35000262 | ||
Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival | Q35011429 | ||
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives | Q35701281 | ||
Updated treatment approach to hepatocellular carcinoma. | Q36097844 | ||
Resection and liver transplantation for hepatocellular carcinoma. | Q36140302 | ||
Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma | Q36845140 | ||
A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring. | Q39815833 | ||
Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit liver tumors. | Q39815846 | ||
Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1alpha in rabbit VX2 liver tumors. | Q40134286 | ||
Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs. | Q41317851 | ||
Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization | Q41947562 | ||
Partition of calibrated tris-acryl gelatin microspheres in the arterial vasculature of embolized nasopharyngeal angiofibromas and paragangliomas. | Q51514323 | ||
Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region | Q73729667 | ||
Hypoxia-inducible factor-1alpha expression in experimental cirrhosis: correlation with vascular endothelial growth factor expression and angiogenesis | Q80575762 | ||
P433 | issue | 10 | |
P304 | page(s) | 1483-1489 | |
P577 | publication date | 2008-10-01 | |
P1433 | published in | Journal of Vascular and Interventional Radiology | Q15766548 |
P1476 | title | Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors | |
P478 | volume | 19 |
Q37867126 | Advances in regional chemotherapy of the liver |
Q38371669 | An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma. |
Q37366556 | Animal models of cancer in interventional radiology |
Q39001861 | Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro |
Q86651932 | Bone targeted bipolar cooled radiofrequency ablation in a VX-2 rabbit femoral carcinoma model |
Q35230282 | Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma? |
Q38155505 | Chemoembolization in patients with hepatocellular carcinoma |
Q87117255 | Chemoembolization of hepatocellular carcinoma |
Q47573274 | Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis |
Q35534035 | Comparison of two different laparotomy methods for modeling rabbit VX2 hepatocarcinoma |
Q36224869 | Considerations for two inoculation methods of rabbit hepatic tumors: Pathology and image features |
Q40575060 | Correlation of volumetric perfusion CT parameters with hypoxia inducible factor-1 alpha expression in a rabbit VX2 tumor model |
Q90708115 | Establishment of Rabbit Liver VX2 Tumor Model Using Percutaneous Puncture Inoculation of Tumor Fragment Guided and Evaluated by Ultrasonography |
Q43206549 | Expression of hypoxia-inducible factor-1alpha in liver tumors after transcatheter arterial embolization in an animal model |
Q34962750 | Hepatic parenchymal changes following transcatheter embolization and chemoembolization in a rabbit tumor model |
Q92669979 | Hyperactivation of IL-6/STAT3 pathway leaded to the poor prognosis of post-TACE HCCs by HIF-1α/SNAI1 axis-induced epithelial to mesenchymal transition |
Q30491780 | Hypoxia as a target for drug combination therapy of liver cancer. |
Q33576048 | Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors |
Q38984450 | In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? |
Q41446079 | Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors |
Q37619480 | Localized hyperthermia with iron oxide-doped yttrium microparticles: steps toward image-guided thermoradiotherapy in liver cancer. |
Q37766546 | Loco-regional treatment of hepatocellular carcinoma |
Q38152999 | Multispectral imaging: a review of its technical aspects and applications in anatomic pathology |
Q34681150 | Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma |
Q37017008 | Potentiality and boundaries of use of sorafenib in patients with hepatocellular carcinoma: awaiting the results of ongoing clinical trials. |
Q46013875 | Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer. |
Q33911988 | Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma |
Q39381670 | RNA interference of hypoxia-inducible factor-1 alpha improves the effects of transcatheter arterial embolization in rat liver tumors |
Q35085486 | Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma |
Q41785826 | Relevance of Rabbit VX2 Tumor Model for Studies on Human Hepatocellular Carcinoma: A MicroRNA-Based Study |
Q54180674 | Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective. |
Q26764896 | The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma |
Q37103489 | Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus |
Q37704703 | Transarterial sorafenib chemoembolization: preliminary study of technical feasibility in a rabbit model |
Q44697301 | Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective |
Q36347609 | Ultrasound-guided RNA interference targeting HIF-1 alpha improves the effects of transarterial chemoembolization in rat liver tumors |
Q44325987 | Unconventional extrahepatic neovascularization after transplant hepatic artery thrombosis: a case report. |
Q30248206 | Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis. |
Search more.